Efficacy of Faviprevir in COVID-19 Treatment

NCT04351295 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

92

Enrollment

OTHER

Sponsor class

Conditions

COVID

Interventions

DRUG: Favipiravir
DRUG: Chloroquine

Sponsor

Tanta University